Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

‘Placebo Therapy’ Ineffective For Long-Term Chronic Pain Relief

By R&D Editors | December 11, 2014

 
Scientists at the University of Liverpool have shown that ‘placebo therapy’ could be effective for short-term pain relief in patients with Complex Regional Pain Syndrome (CRPS), but does not have a lasting impact. 
 
For the treatment of pain, the magnitude of a ‘placebo-effect’ – a combination of the pain getting better naturally and the brain believing that a dummy drug intervention can help – is thought to be as much as a 25% to 35% reduction in patient discomfort.
 
Alongside such an effective ‘therapy’, however, it is unclear what impact a ‘real’ drug treatment can have. 
 
It is known that patients with a variety of health conditions often get better with placebo therapies, even though these have no specific health benefits – they simply ‘look’ like the real thing. Studies into irritable bowel syndrome, for example, have shown that patients improve with placebo ‘treatment’, and placebo is even discussed as a recommend course of therapy in some cases. 
 
Clinical trials
 
The Liverpool team assessed the results of all clinical trials relating to long-term CRPS patients – a condition that can develop after small trauma to the limbs – conducted in the UK and internationally, to understand the effect of placebo therapy and how large the impact is on patients with the condition. 
 
Dr Andreas Goebel, from the University’s Institute of Translational Medicine, explains: We found that patients experienced significant pain relief minutes after a placebo therapy, such as salt water injections, but unexpectedly at a later time, and even with repeated placebo applications, there was minimal or no impact on reducing the symptoms of the condition.” 
 
The results suggest that CRPS will not improve naturally over time, and there is little fluctuation in the pain intensity of the condition. 
 
Dr Goebel added: “It seems that the brain of CRPS patients cannot be easily ‘tricked’ into believing that a dummy intervention is effective. This means that health specialists should be cautious when considering placebo interventions for these patients.” 
 
The research is published in the journal, Pain.
 
Source: University of Liverpool
 

Related Articles Read More >

New dangers in the woods — and the hope that research offers us
Novel mass spectrometry solution simplifies insight gathering into macromolecular complexes
ENPICOM launches display solution to accelerate antibody selection while maximizing precision
Thermo Fisher Scientific autoimmune-testing instruments now available in the U.S.
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars